Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Myomo, Inc.

< Previous 1 2 3 Next >
Myomo Reports Third Quarter 2022 Financial Results Featuring Strong Authorizations and Orders and Record Backlog
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Third Quarter Financial Results on November 10, 2022
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Present at the H.C. Wainwright 24th Annual Global Investment Conference
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Receives Order from the Louis Stokes Cleveland VA Medical Center to Support MyoPro Clinical Trial
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Second Quarter Financial Results on August 3, 2022
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Second Quarter Preliminary Revenue and Record Pipeline Additions
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo To Present at the Sidoti Summer Small Cap Virtual Investor Conference
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports First Quarter 2022 Financial Results
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report First Quarter Financial Results on May 11, 2022
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Strengthens Intellectual Property Portfolio With Receipt of Key Patent in Japan
From Myomo, Inc.
Via Business Wire
Tickers MYO
Independent Research with Myomo’s MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Chronic Moderate-to-Severe Arm Weakness
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Present at the Sidoti Winter Small Cap Conference
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Provides Update on MyoPro® Insurance Reimbursement
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces MyoPro® 2+
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Third Quarter 2021 Financial Results Feature Record Revenue
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo, Inc. to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5th
From Myomo, Inc.
Via AccessWire
Tickers MYO
Myomo, Inc. Announces Granting of Patents in China and Hong Kong
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo, Inc. Announces Participation in Three September Investment Conferences
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Second Quarter 2021 Financial Results on August 9, 2021
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Receives Accreditation from HQAA
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo, Inc. Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo, Inc. Stock Added to Russell Microcap® Index
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Present at Sidoti Virtual Investor Conference on June 23, 2021
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Shareholders Elect Dr. Milton Morris as Director
From Myomo, Inc.
Via Business Wire
Tickers MYO
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.